Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages

References

• Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016 Mar;16(2):218–224. doi: 10.1016/j.pan.2016.02.001
   PubMed Web of Science ®Google Scholar
• Klöppel G, Maillet B. Chronic pancreatitis: evolution of the disease. Hepatogastroenterology. 1991 Oct;38(5):408–412.
   PubMedGoogle Scholar
• Sze KC, Pirola RC, Apte MV, et al. Current options for the diagnosis of chronic pancreatitis. Expert Rev Mol Diagn. 2014 Mar;14(2):199–215. doi: 10.1586/14737159.2014.883277
   PubMed Web of Science ®Google Scholar
• Hirota M, Shimosegawa T, Masamune A, et al. The sixth nationwide epidemiological survey of chronic pancreatitis in Japan. Pancreatology. 2012 Mar;12(2):79–84. doi: 10.1016/j.pan.2012.02.005
   PubMed Web of Science ®Google Scholar
• Yadav D, Timmons L, Benson JT, et al. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol. 2011 Dec;106(12):2192–2199. doi: 10.1038/ajg.2011.328
   PubMed Web of Science ®Google Scholar
• Jupp J, Fine D, Johnson CD. The epidemiology and socioeconomic impact of chronic pancreatitis. Best Pract Res Clin Gastroenterol. 2010 Jun;24(3):219–231. doi: 10.1016/j.bpg.2010.03.005
   PubMed Web of Science ®Google Scholar
• Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):175–184. doi: 10.1038/s41575-018-0087-5
   PubMed Web of Science ®Google Scholar
• Becker U, Timmermann A, Ekholm O, et al. Alcohol drinking patterns and risk of developing acute and chronic pancreatitis. Alcohol Alcohol. 2023 Jul 10;58(4):357–365. doi: 10.1093/alcalc/agad012
   PubMed Web of Science ®Google Scholar
• Wang YC, Mao XT, Yu D, et al. Alcohol amplifies the association between common variants at PRSS1-PRSS2 locus and chronic pancreatitis in a dose-dependent manner. Gut. 2022 Nov;71(11):2369–2371. doi: 10.1136/gutjnl-2021-326670
   PubMed Web of Science ®Google Scholar
• Liyen Cartelle A, Bocchino RL, Shah I, et al. Smoking is associated with worse clinical outcomes in chronic pancreatitis. Dig Dis Sci. 2023 Jun;68(6):2667–2673. doi: 10.1007/s10620-023-07841-4
   PubMed Web of Science ®Google Scholar
• Hansen SEJ, Nordestgaard BG, Langsted A. Smoking as the most important risk factor for chronic pancreatitis in the general population. Eur J Epidemiol. 2023 Jan;38(1):95–107. doi: 10.1007/s10654-022-00945-7
   PubMedGoogle Scholar
• Jeon CY, Feldman R, Althouse A, et al. Lifetime smoking history and cohort-based smoking prevalence in chronic pancreatitis. Pancreatology. 2021 May 29;21(6):1183–1190. doi: 10.1016/j.pan.2021.05.302
   Web of Science ®Google Scholar
• de Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management. United Eur Gastroenterol J. 2018 Jun;6(5):649–655. doi: 10.1177/2050640618755002
   PubMed Web of Science ®Google Scholar
• LaRusch J, Whitcomb DC. Genetics of pancreatitis. Curr Opin Gastroenterol. 2011 Sep;27(5):467–474. doi: 10.1097/MOG.0b013e328349e2f8
   PubMed Web of Science ®Google Scholar
• Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001 Feb;120(3):682–707. doi: 10.1053/gast.2001.22586
   PubMed Web of Science ®Google Scholar
• Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995 Jul;40(7):1561–1568. doi: 10.1007/BF02285209
   PubMed Web of Science ®Google Scholar
• Manohar M, Verma AK, Venkateshaiah SU, et al. Pathogenic mechanisms of pancreatitis. World J Gastrointest Pharmacol Ther. 2017 Feb 6;8(1):10–25. doi: 10.4292/wjgpt.v8.i1.10
   PubMedGoogle Scholar
• Banks PA, Conwell DL, Toskes PP. The management of acute and chronic pancreatitis. Gastroenterol Hepatol (NY). 2010 Feb;6(2 Suppl 3):1–16.
   PubMedGoogle Scholar
• Anaizi A, Hart PA, Conwell DL. Diagnosing chronic pancreatitis. Dig Dis Sci. 2017 Jul;62(7):1713–1720. doi: 10.1007/s10620-017-4493-2
   PubMed Web of Science ®Google Scholar
• Dugic A, Hagström H, Dahlman I, et al. Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes. United Eur Gastroenterol J. 2023 Feb;11(1):79–91. doi: 10.1002/ueg2.12344
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Petrov MS, Andersen DK, et al. Diabetes in chronic pancreatitis: risk factors and natural history. Curr Opin Gastroenterol. 2021;37(5):526–531. doi: 10.1097/MOG.0000000000000756
   PubMed Web of Science ®Google Scholar
• Dhar P, Kalghatgi S, Saraf V. Pancreatic cancer in chronic pancreatitis. Indian J Surg Oncol. 2015 Mar;6(1):57–62. doi: 10.1007/s13193-014-0373-9
   PubMedGoogle Scholar
• Kirkegård J, Mortensen FV, Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis. Am J Gastroenterol. 2017 Sep;112(9):1366–1372. doi: 10.1038/ajg.2017.218
   PubMed Web of Science ®Google Scholar
• Kim HS, Gweon TG, Park SH, et al. Incidence and risk of pancreatic cancer in patients with chronic pancreatitis: defining the optimal subgroup for surveillance. Sci Rep. 2023 Jan 3;13(1):106. doi: 10.1038/s41598-022-26411-8
   PubMed Web of Science ®Google Scholar
• Kwon CI, Cho JH, Choi SH, et al. Recent advances in the diagnosis and management of chronic pancreatitis. Korean J Intern Med. 2019 Mar;34(2):242–260. doi: 10.3904/kjim.2019.051
   PubMed Web of Science ®Google Scholar
• Domínguez-Muñoz JE, Phillips M. Nutritional therapy in chronic pancreatitis. Gastroenterol Clin North Am. 2018 Mar;47(1):95–106. doi: 10.1016/j.gtc.2017.09.004
   PubMed Web of Science ®Google Scholar
• de la Iglesia-García D, Huang W, Szatmary P, et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut. 2017 Aug;66(8):1354–1355. doi: 10.1136/gutjnl-2016-312529
   PubMed Web of Science ®Google Scholar
• Familiari P, Boškoski I, Bove V, et al. ERCP for biliary strictures associated with chronic pancreatitis. Gastrointest Endosc Clin N Am. 2013 Oct;23(4):833–845. doi: 10.1016/j.giec.2013.06.007
   PubMedGoogle Scholar
• Terzin V, Takács R, Lengyel C, et al. Improved glycemic control in pancreatic diabetes through intensive conservative insulin therapy. Pancreatology. 2012 Mar;12(2):100–103. doi: 10.1016/j.pan.2012.01.004
   PubMed Web of Science ®Google Scholar
• Singh S, Chang HY, Richards TM, et al. Glucagon like peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013 Apr 8;173(7):534–539. doi: 10.1001/jamainternmed.2013.2720
   PubMed Web of Science ®Google Scholar
• Xiang H, Yu H, Zhou Q, et al. Macrophages: a rising star in immunotherapy for chronic pancreatitis. Pharmacol Res. 2022 Nov;185:106508. doi: 10.1016/j.phrs.2022.106508
   PubMed Web of Science ®Google Scholar
• Hu F, Lou N, Jiao J, et al. Macrophages in pancreatitis: mechanisms and therapeutic potential. Biomed Pharmacother. 2020 Nov;131:110693. doi: 10.1016/j.biopha.2020.110693
   PubMed Web of Science ®Google Scholar
• Erkan M, Reiser-Erkan C, Michalski CW, et al. The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance. Curr Mol Med. 2012 Mar;12(3):288–303. doi: 10.2174/156652412799218921
   PubMed Web of Science ®Google Scholar
• Phillips P. Pancreatic Cancer and Tumor Microenvironment. Trivandrum (India): Transworld Research Network; 2012. Chapter 3.
   Google Scholar
• Apte MV, Park S, Phillips PA, et al. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas. 2004 Oct;29(3):179–187. doi: 10.1097/00006676-200410000-00002
   PubMed Web of Science ®Google Scholar
• Apte MV, Pirola RC, Wilson JS. Battle-scarred pancreas: role of alcohol and pancreatic stellate cells in pancreatic fibrosis. J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3(s3):S97–s101. doi: 10.1111/j.1440-1746.2006.04587.x
   PubMedGoogle Scholar
• Phillips PA, McCarroll JA, Park S, et al. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut. 2003 Feb;52(2):275–282. doi: 10.1136/gut.52.2.275
   PubMed Web of Science ®Google Scholar
• Apte MV, Haber PS, Applegate TL, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 1998 Jul;43(1):128–133. doi: 10.1136/gut.43.1.128
   PubMed Web of Science ®Google Scholar
• Bachem MG, Schneider E, Gross H, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 1998 Aug;115(2):421–432. doi: 10.1016/S0016-5085(98)70209-4
   PubMed Web of Science ®Google Scholar
• Apte MV, Haber PS, Darby SJ, et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 1999 Apr;44(4):534–541. doi: 10.1136/gut.44.4.534
   PubMed Web of Science ®Google Scholar
• Andoh A, Takaya H, Saotome T, et al. Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology. 2000 Jul;119(1):211–219. doi: 10.1053/gast.2000.8538
   PubMed Web of Science ®Google Scholar
• Masamune A, Kikuta K, Satoh M, et al. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. J Biol Chem. 2002 Jan 4;277(1):141–147. doi: 10.1074/jbc.M107582200
   PubMed Web of Science ®Google Scholar
• Bynigeri RR, Jakkampudi A, Jangala R, et al. Pancreatic stellate cell: Pandora’s box for pancreatic disease biology. World J Gastroenterol. 2017 Jan 21;23(3):382–405. doi: 10.3748/wjg.v23.i3.382
   PubMed Web of Science ®Google Scholar
• Shek FW, Benyon RC, Walker FM, et al. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol. 2002 May;160(5):1787–1798. doi: 10.1016/S0002-9440(10)61125-X
   PubMed Web of Science ®Google Scholar
• Yan B, Cheng L, Jiang Z, et al. Resveratrol inhibits ROS-Promoted activation and glycolysis of pancreatic stellate cells via suppression of miR-21. Oxid Med Cell Longev. 2018;2018:1346958. doi: 10.1155/2018/1346958
   PubMed Web of Science ®Google Scholar
• Lei J, Huo X, Duan W, et al. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Cancer Lett. 2014 May 28;347(1):129–138. doi: 10.1016/j.canlet.2014.02.003
   PubMed Web of Science ®Google Scholar
• Mews P, Phillips P, Fahmy R, et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut. 2002 Apr;50(4):535–541. doi: 10.1136/gut.50.4.535
   PubMed Web of Science ®Google Scholar
• Masamune A, Sakai Y, Kikuta K, et al. Activated rat pancreatic stellate cells express intercellular adhesion molecule-1 (ICAM-1) in vitro. Pancreas. 2002 Jul;25(1):78–85. doi: 10.1097/00006676-200207000-00018
   PubMed Web of Science ®Google Scholar
• Marzoq AJ, Giese N, Hoheisel JD, et al. Proteome variations in pancreatic stellate cells upon stimulation with proinflammatory factors. J Biol Chem. 2013 Nov 8;288(45):32517–32527. doi: 10.1074/jbc.M113.488387
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang WQ, Liu XY, et al. Immune cells and immune cell-targeted therapy in chronic pancreatitis. Front Oncol. 2023;13:1151103. doi: 10.3389/fonc.2023.1151103
   PubMedGoogle Scholar
• Pitchumoni CS. Pathogenesis of alcohol-induced chronic pancreatitis: facts, perceptions, and misperceptions. Surg Clin North Am. 2001 Apr;81(2):379–390. doi: 10.1016/S0039-6109(05)70125-0
   PubMed Web of Science ®Google Scholar
• Luaces-Regueira M, Castiñeira-Alvariño M, Castro-Manzanares M, et al. Pathophysiological events associated with pancreatitis in response to tobacco: an in vitro comparative study with ethanol in primary acinar cell culture. Pancreas. 2018 Nov;47(10):1304–1311. doi: 10.1097/MPA.0000000000001180
   PubMed Web of Science ®Google Scholar
• Chowdhury P, Udupa KB. Nicotine as a mitogenic stimulus for pancreatic acinar cell proliferation. World J Gastroenterol. 2006 Dec 14;12(46):7428–7432. doi: 10.3748/wjg.v12.i46.7428
   PubMed Web of Science ®Google Scholar
• Wittel UA, Pandey KK, Andrianifahanana M, et al. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol. 2006 Jan;101(1):148–159. doi: 10.1111/j.1572-0241.2006.00405.x
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang L, Yu C, et al. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res. 2014 Jan 7;2(1):1. doi: 10.1186/2050-7771-2-1
   PubMedGoogle Scholar
• Zhang H-W, Xie G-H, Ren X-H, et al. Bursicon homodimers induce the innate immunity via relish in Procambarus clarkii. Fish Shellfish Immunol. 2020 Apr 1;99:555–561. doi: 10.1016/j.fsi.2020.02.053
   PubMed Web of Science ®Google Scholar
• Orecchioni M, Ghosheh Y, Pramod AB, et al. Macrophage polarization: different gene signatures in M1(LPS+) vs. Classically and M2(LPS-) vs alternatively activated macrophages. Front Immunol. 2019;10:1084. doi: 10.3389/fimmu.2019.01084
   PubMed Web of Science ®Google Scholar
• Yao Y, Xu XH, Jin L. Macrophage polarization in physiological and pathological pregnancy. Front Immunol. 2019;10:792. doi: 10.3389/fimmu.2019.00792
   PubMed Web of Science ®Google Scholar
• Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016 Mar 15;44(3):450–462. doi: 10.1016/j.immuni.2016.02.015
   PubMed Web of Science ®Google Scholar
• Sendler M, Weiss FU, Golchert J, et al. Cathepsin B-Mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice. Gastroenterology. 2018 Feb;154(3):704–718.e10. doi: 10.1053/j.gastro.2017.10.018
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang L, Shi J, et al. Macrophage phenotypic switch orchestrates the inflammation and repair/regeneration following acute pancreatitis injury. EBioMedicine. 2020 Aug;58:102920. doi: 10.1016/j.ebiom.2020.102920
   PubMed Web of Science ®Google Scholar
• Sahay P, Bava EP, Iyer S, et al. Modulation of macrophage polarity for treatment of acute pancreatitis: are we there yet? EBioMedicine. 2020 Oct;60:103002. doi: 10.1016/j.ebiom.2020.103002
   PubMed Web of Science ®Google Scholar
• Iyer S, Bawa EP, Tarique M, et al. Know thy enemy—understanding the role of inflammation in severe acute pancreatitis. Gastroenterology. 2020 Jan 1;158(1):46–48. doi: 10.1053/j.gastro.2019.11.039
   PubMed Web of Science ®Google Scholar
• Gea-Sorlí S, Closa D. Role of macrophages in the progression of acute pancreatitis. World J Gastrointest Pharmacol Ther. 2010 Oct 6;1(5):107–111. doi: 10.4292/wjgpt.v1.i5.107
   PubMedGoogle Scholar
• Bhatia M, Wong FL, Cao Y, et al. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5(2–3):132–144. doi: 10.1159/000085265
   PubMed Web of Science ®Google Scholar
• Xue J, Sharma V, Hsieh MH, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 2015 May 18;6(1):7158. doi: 10.1038/ncomms8158
   PubMedGoogle Scholar
• Smith WL, Dl D, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69(1):145–182. doi: 10.1146/annurev.biochem.69.1.145
   PubMedGoogle Scholar
• Schlosser W, Schlosser S, Ramadani M, et al. Cyclooxygenase-2 is overexpressed in chronic pancreatitis. Pancreas. 2002 Jul;25(1):26–30. doi: 10.1097/00006676-200207000-00008
   PubMed Web of Science ®Google Scholar
• Koliopanos A, Friess H, Kleeff J, et al. Cyclooxygenase 2 expression in chronic pancreatitis: correlation with stage of the disease and diabetes mellitus. Digestion. 2001;64(4):240–247. doi: 10.1159/000048868
   PubMed Web of Science ®Google Scholar
• Zabel-Langhennig A, Holler B, Engeland K, et al. Cyclooxygenase-2 transcription is stimulated and amylase secretion is inhibited in pancreatic acinar cells after induction of acute pancreatitis. Biochem Biophys Res Commun. 1999 Nov 19;265(2):545–549. doi: 10.1006/bbrc.1999.1719
   PubMed Web of Science ®Google Scholar
• Polito F, Bitto A, Irrera N, et al. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis. Br J Pharmacol. 2010 Nov;161(5):1002–1011. doi: 10.1111/j.1476-5381.2010.00933.x
   PubMed Web of Science ®Google Scholar
• Reding T, Bimmler D, Perren A, et al. A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (Wbn/kob rats): significant reduction of macrophage infiltration and fibrosis. Gut. 2006 Aug;55(8):1165–1173. doi: 10.1136/gut.2005.077925
   PubMed Web of Science ®Google Scholar
• Horton HR. Vioxx, the implosion of Merck, and aftershocks at the FDA. Lancet. 2004 Dec 4–10;364(9450):1995–1996. doi: 10.1016/S0140-6736(04)17523-5
   PubMed Web of Science ®Google Scholar
• Haanen C. Sulindac and its derivatives: a novel class of anticancer agents. Curr Opin Invest Drugs. 2001 May;2(5):677–683.
   PubMedGoogle Scholar
• Bai H, Chen X, Zhang L, et al. The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitis. BMC Gastroenterol. 2012 Aug 24;12(1):115. doi: 10.1186/1471-230X-12-115
   PubMedGoogle Scholar
• Wu KK. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin Vasc Med. 2003 May;3(2):107–112.
   PubMedGoogle Scholar
• Vane JR, Botting RM. Mechanism of action of aspirin-like drugs. Semin Arthritis Rheum. 1997 Jun;26(6 Suppl 1):2–10. doi: 10.1016/S0049-0172(97)80046-7
   PubMed Web of Science ®Google Scholar
• Xu XF, Fan JW, Xin JQ, et al. Aspirin ameliorates pancreatic inflammation and fibrosis by inhibiting COX-2 expression in experimental chronic pancreatitis. J Inflamm Res. 2022;15:4737–4749. doi: 10.2147/JIR.S375383
   PubMed Web of Science ®Google Scholar
• Han S, Conwell DL, Li L, et al. The phase 1/2 trial of indomethacin in chronic pancreatitis (The PAIR trial): Protocol for a parallel multi-center randomized controlled trial. Pancreatology. 2023 Jan;23(1):42–47. doi: 10.1016/j.pan.2022.12.008
   PubMed Web of Science ®Google Scholar
• Fan J, Duan L, Wu N, et al. Baicalin ameliorates pancreatic fibrosis by inhibiting the activation of pancreatic stellate cells in mice with chronic pancreatitis [original research]. Front Pharmacol. 2021 Jan 18;11:11. doi: 10.3389/fphar.2020.607133
   Web of Science ®Google Scholar
• Paul WN, Carlo A, Williamson ZB, et al. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Respir J. 2016;47(1):243. doi: 10.1183/13993003.00026-2015
   PubMed Web of Science ®Google Scholar
• Shimizu T, Kuroda T, Hata S, et al. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney. Kidney Int. 1998 Jul 1;54(1):99–109. doi: 10.1046/j.1523-1755.1998.00962.x
   PubMed Web of Science ®Google Scholar
• Garcı́a L, Hernández I, Sandoval A, et al. Pirfenidone effectively reverses experimental liver fibrosis. J hepatol. 2002 Dec 1;37(6):797–805. doi: 10.1016/S0168-8278(02)00272-6
   PubMed Web of Science ®Google Scholar
• Palathingal Bava E, George J, Tarique M, et al. Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine models. JCI Insight. 2022 Jan 25;7(2). doi: 10.1172/jci.insight.141108
   PubMed Web of Science ®Google Scholar
• Palathingal Bava E, George J, Iyer S, et al. Pirfenidone ameliorates chronic pancreatitis in mouse models through immune and cytokine modulation. Pancreatology. 2022 Jun;22(5):553–563. doi: 10.1016/j.pan.2022.05.002
   PubMed Web of Science ®Google Scholar
• Su SB, Motoo Y, Iovanna JL, et al. Effect of camostat mesilate on the expression of pancreatitis-associated protein (PAP), p8, and cytokines in rat spontaneous chronic pancreatitis. Pancreas. 2001 Aug;23(2):134–140. doi: 10.1097/00006676-200108000-00003
   PubMed Web of Science ®Google Scholar
• Ota S, Hara Y, Kanoh S, et al. Acute eosinophilic pneumonia caused by camostat mesilate: the first case report. Respir Med Case Rep. 2016;19:21–23. doi: 10.1016/j.rmcr.2016.06.005
   PubMedGoogle Scholar
• Ramsey ML, Nuttall J, Hart PA. On behalf of the TIT. A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC). Trials. 2019 Aug 14;20(1):501. doi: 10.1186/s13063-019-3606-y
   PubMedGoogle Scholar
• Zeng XP, Wang LJ, Guo HL, et al. Dasatinib ameliorates chronic pancreatitis induced by caerulein via anti-fibrotic and anti-inflammatory mechanism. Pharmacol Res. 2019 Sep;147:104357. doi: 10.1016/j.phrs.2019.104357
   PubMed Web of Science ®Google Scholar
• Hilberg F, Roth GJ, Krssak M, et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res. 2008 Jun 15;68(12):4774–4782. doi: 10.1158/0008-5472.CAN-07-6307
   PubMed Web of Science ®Google Scholar
• Richeldi L, Costabel U, Selman M, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med. 2011 Sep 22;365(12):1079–1087. doi: 10.1056/NEJMoa1103690
   PubMed Web of Science ®Google Scholar
• Öztürk Akcora B, Storm G, Prakash J, et al. Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl(4)-induced liver fibrogenesis mouse model. Sci Rep. 2017 Mar 14;7(1):44545. doi: 10.1038/srep44545
   PubMedGoogle Scholar
• Feng L, Li W, Chao Y, et al. Synergistic inhibition of renal fibrosis by nintedanib and gefitinib in a murine model of obstructive nephropathy. Kidney Dis (Basel). 2021 Jan;7(1):34–49. doi: 10.1159/000509670
   PubMed Web of Science ®Google Scholar
• Han C, Wang L-J, Dong Z-Q, et al. Nintedanib alleviates chronic pancreatitis by inhibiting the activation of pancreatic stellate cells via the JAK/STAT3 and ERK1/2 pathways. Dig Dis Sci. 2023 Sep 1;68(9):3644–3659. doi: 10.1007/s10620-023-08052-7
   PubMed Web of Science ®Google Scholar
• Komar HM, Serpa G, Kerscher C, et al. Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo. Sci Rep. 2017 May 11;7(1):1787. doi: 10.1038/s41598-017-01973-0
   PubMedGoogle Scholar
• Yu JH, Kim KH, Kim H. Suppression of IL-1β expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells. Biochem Pharmacol. 2006 Nov 30;72(11):1555–1562. doi: 10.1016/j.bcp.2006.07.008
   PubMed Web of Science ®Google Scholar
• Lin Y, Chen Y, Feng W, et al. STAT5 promotes chronic pancreatitis by enhancing GM-CSF-dependent neutrophil augmentation. J Leukocyte Biol. 2021 Aug;110(2):293–300. doi: 10.1002/JLB.3MA1020-647R
   PubMed Web of Science ®Google Scholar
• Shu B, Zhang M, Xie R, et al. BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. J Cell Sci. 2011;124(20):3428–3440. doi: 10.1242/jcs.083659
   PubMed Web of Science ®Google Scholar
• Bush KT, Sakurai H, Steer DL, et al. TGF-beta superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud. Dev Biol. 2004 Feb 15;266(2):285–298. doi: 10.1016/j.ydbio.2003.10.023
   PubMed Web of Science ®Google Scholar
• Ahnfelt-Rønne J, Ravassard P, Pardanaud-Glavieux C, et al. Mesenchymal bone morphogenetic protein signaling is required for normal pancreas development. Diabetes. 2010;59(8):1948–1956. doi: 10.2337/db09-1010
   PubMed Web of Science ®Google Scholar
• Ye L, Lewis-Russell JM, Kyanaston HG, et al. Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol Histopathol. 2007 Oct;22(10):1129–1147. doi: 10.14670/HH-22.1129
   PubMed Web of Science ®Google Scholar
• Cao Y, Drake M, Davis J, et al. Opposing roles of BMP and TGF-β signaling pathways in pancreatitis: mechanisms and therapeutic implication. Adv Res Gastroenterol Hepatol. 2019;13(5). doi: 10.19080/ARGH.2019.13.555871
   PubMedGoogle Scholar
• Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003 Jul;9(7):964–968. doi: 10.1038/nm888
   PubMed Web of Science ®Google Scholar
• Myllärniemi M, Lindholm P, Ryynänen MJ, et al. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am J Respir Crit Care Med. 2008 Feb 1;177(3):321–329. doi: 10.1164/rccm.200706-945OC
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Iimuro Y, Otogawa K, et al. Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut. 2007 May;56(5):706–714. doi: 10.1136/gut.2006.092460
   PubMed Web of Science ®Google Scholar
• Gao X, Cao Y, Staloch DA, et al. Bone morphogenetic protein signaling protects against cerulein-induced pancreatic fibrosis. PLOS ONE. 2014;9(2):e89114. doi: 10.1371/journal.pone.0089114
   PubMed Web of Science ®Google Scholar
• Wang N, Zhao TT, Li SM, et al. Fibroblast growth factor 21 ameliorates pancreatic fibrogenesis via regulating polarization of macrophages. Exp Cell Res. 2019 Sep 1;382(1):111457. doi: 10.1016/j.yexcr.2019.06.002
   PubMed Web of Science ®Google Scholar
• Seegräber M, Srour J, Walter A, et al. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol. 2018 May;11(5):467–474. doi: 10.1080/17512433.2018.1449642
   PubMed Web of Science ®Google Scholar
• Simpson EL, Flohr C, Eichenfield LF, et al. Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: a randomized, placebo-controlled phase II trial (TREBLE). J Am Acad Dermatol. 2018 May;78(5):863–871.e11. doi: 10.1016/j.jaad.2018.01.017
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Blauvelt A, Guttman-Yassky E, et al. Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2). Br J Dermatol. 2021 Mar;184(3):437–449. doi: 10.1111/bjd.19574
   PubMed Web of Science ®Google Scholar
• Apte MV, Haber PS, Applegate TL, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 1998;43(1):128. doi: 10.1136/gut.43.1.128
   PubMed Web of Science ®Google Scholar
• McCarroll JA, Phillips PA, Santucci N, et al. Vitamin a inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis. Gut. 2006 Jan;55(1):79–89. doi: 10.1136/gut.2005.064543
   PubMed Web of Science ®Google Scholar
• Sarper M, Cortes E, Lieberthal TJ, et al. ATRA modulates mechanical activation of TGF-β by pancreatic stellate cells. Sci Rep. 2016 Jul 4;6(1):27639. doi: 10.1038/srep27639
   PubMedGoogle Scholar
• Xiao W, Jiang W, Shen J, et al. Retinoic acid ameliorates pancreatic fibrosis and inhibits the activation of pancreatic stellate cells in mice with experimental chronic pancreatitis via suppressing the wnt/β-catenin signaling pathway. PLOS ONE. 2015;10(11):e0141462. doi: 10.1371/journal.pone.0141462
   PubMed Web of Science ®Google Scholar
• Ishiwatari H, Sato Y, Murase K, et al. Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes. Gut. 2013 Sep;62(9):1328–1339. doi: 10.1136/gutjnl-2011-301746
   PubMed Web of Science ®Google Scholar
• Mann ST, Stracke H, Lange U, et al. Vitamin D3 in patients with various grades of chronic pancreatitis, according to morphological and functional criteria of the pancreas. Dig Dis Sci. 2003 Mar;48(3):533–538. doi: 10.1023/A:1022540816990
   PubMed Web of Science ®Google Scholar
• Cai F, Hu C, Chen CJ, et al. Vitamin D and pancreatitis: a narrative review of current evidence. Nutrients. 2022 May 18;14(10):2113. doi: 10.3390/nu14102113
   PubMed Web of Science ®Google Scholar
• Zheng M, Gao R. Vitamin D: a potential star for treating chronic pancreatitis [review]. Front Pharmacol. 2022 Jun 6;13:13. doi: 10.3389/fphar.2022.902639
   Web of Science ®Google Scholar
• Wallbaum P, Rohde S, Ehlers L, et al. Antifibrogenic effects of vitamin D derivatives on mouse pancreatic stellate cells. World J Gastroenterol. 2018 Jan 14;24(2):170–178. doi: 10.3748/wjg.v24.i2.170
   PubMed Web of Science ®Google Scholar
• Sherman MH, Yu RT, Engle DD, et al. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell. 2014 Sep 25;159(1):80–93. doi: 10.1016/j.cell.2014.08.007
   PubMed Web of Science ®Google Scholar
• Kang Z-S, Wang C, Han X-L, et al. Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis. Eur J Med Chem. 2018 Feb 25;146:541–553. doi: 10.1016/j.ejmech.2018.01.073
   PubMed Web of Science ®Google Scholar
• Olesen SS, Poulsen JL, Vestergaard P, et al. Vitamin-D deficiency in patients with chronic pancreatitis - Prevalence and pitfalls. Pancreatology. 2017 Jan;17(1):22–23. doi: 10.1016/j.pan.2016.10.007
   PubMed Web of Science ®Google Scholar
• Zheng M, Gao R. Vitamin D: a potential star for treating chronic pancreatitis. Front Pharmacol. 2022;13:902639. doi: 10.3389/fphar.2022.902639
   PubMed Web of Science ®Google Scholar
• Seelinger G, Merfort I, Schempp CM. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 2008 Nov;74(14):1667–1677. doi: 10.1055/s-0028-1088314
   PubMed Web of Science ®Google Scholar
• Yu Q, Zhu J, Sheng X, et al. Luteolin ameliorates experimental chronic pancreatitis induced by trinitrobenzenesulfonic acid in rats. Pancreas. 2018 May;47(5):568–576. doi: 10.1097/MPA.0000000000001035
   PubMed Web of Science ®Google Scholar
• Huang X, Bhugul PA, Fan G, et al. Luteolin inhibits pancreatitis‑induced acinar‑ductal metaplasia, proliferation and epithelial‑mesenchymal transition of acinar cells. Mol Med Rep. 2018 Mar;17(3):3681–3689. doi: 10.3892/mmr.2017.8327
   PubMed Web of Science ®Google Scholar
• Choi JW, Lee SK, Kim MJ, et al. Piperine ameliorates the severity of fibrosis via inhibition of TGF‑β/SMAD signaling in a mouse model of chronic pancreatitis. Mol Med Rep. 2019 Oct;20(4):3709–3718. doi: 10.3892/mmr.2019.10635
   PubMed Web of Science ®Google Scholar
• Wang LJ, He L, Hao L, et al. Isoliquiritigenin ameliorates caerulein-induced chronic pancreatitis by inhibiting the activation of PSCs and pancreatic infiltration of macrophages. J Cell Mol Med. 2020 Sep;24(17):9667–9681. doi: 10.1111/jcmm.15498
   PubMed Web of Science ®Google Scholar
• Bansod S, Aslam Saifi M, Khurana A, et al. Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating β-catenin/Smad in a sirtuin-dependent way. Pharmacol Res. 2020 Jun;156:104756. doi: 10.1016/j.phrs.2020.104756
   PubMed Web of Science ®Google Scholar
• Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011 Sep 15;25(18):1895–1908. doi: 10.1101/gad.17420111
   PubMed Web of Science ®Google Scholar
• Mishra R, Cool BL, Laderoute KR, et al. AMP-activated protein kinase inhibits transforming growth factor-β-induced smad3-dependent transcription and myofibroblast transdifferentiation*. J Biol Chem. 2008 Apr 18;283(16):10461–10469. doi: 10.1074/jbc.M800902200
   PubMed Web of Science ®Google Scholar
• Jin Y, Liu S, Ma Q, et al. Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes. Eur J Pharmacol. 2017 Jan 5;794:106–114. doi: 10.1016/j.ejphar.2016.11.037
   PubMed Web of Science ®Google Scholar
• Zhang X, Liang D, Lian X, et al. Berberine activates Nrf2 nuclear translocation and inhibits apoptosis induced by high glucose in renal tubular epithelial cells through a phosphatidylinositol 3-kinase/Akt-dependent mechanism. Apoptosis. 2016 Jun;21(6):721–736. doi: 10.1007/s10495-016-1234-5
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao L, Chen J, et al. Pharmacological modulation of Nrf2/HO-1 signaling pathway as a therapeutic target of parkinson’s disease. Front Pharmacol. 2021;12:757161. doi: 10.3389/fphar.2021.757161
   PubMed Web of Science ®Google Scholar
• Bansod S, Doijad N, Godugu C. Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization. Toxicol Appl Pharmacol. 2020 Sep 15;403:115162. doi: 10.1016/j.taap.2020.115162
   PubMed Web of Science ®Google Scholar
• Khurana A, Saifi MA, Godugu C. Yttrium oxide nanoparticles attenuate l-arginine induced chronic pancreatitis. Biol Trace Elem Res. 2023 Jul;201(7):3404–3417. doi: 10.1007/s12011-022-03446-6
   PubMed Web of Science ®Google Scholar
• Ghaleb AM, Yang VW. Krüppel-like factor 4 (KLF4): what we currently know. Gene. 2017 May 5;611:27–37. doi: 10.1016/j.gene.2017.02.025
   PubMed Web of Science ®Google Scholar
• Yang X, Mathis BJ, Huang Y, et al. KLF4 promotes diabetic chronic wound healing by suppressing Th17 cell differentiation in an MDSC-dependent manner. J Diabetes Res. 2021 Sep 15;2021:1–9. doi: 10.1155/2021/7945117
   Web of Science ®Google Scholar
• Li W, Wang J, Li Z. ALK5 deficiency inhibits macrophage inflammation and lipid loading by targeting KLF4. Biosci Rep. 2020 Mar 27;40(3). doi: 10.1042/BSR20194188
   Google Scholar
• Shen K, Li R, Zhang X, et al. Acetyl oxygen benzoate engeletin ester promotes KLF4 degradation leading to the attenuation of pulmonary fibrosis via inhibiting TGFβ1-smad/p38MAPK-lnc865/lnc556-miR-29b-2-5p-STAT3 signal pathway. Aging (Albany NY). 2021 Apr 30;13(10):13807–13821. doi: 10.18632/aging.202975
   PubMedGoogle Scholar
• Wang X, Yu L, Chen Y, et al. The Kruppel-like factor 4-signal transducer and activator of transcription 5A axis promotes pancreatic fibrosis in mice with caerulein-induced chronic pancreatitis. Exp Anim. 2023 Aug 7;72(3):379–388. doi: 10.1538/expanim.22-0147
   PubMed Web of Science ®Google Scholar
• Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007 May 2;297(17):1901–1908. doi: 10.1001/jama.297.17.1901
   PubMed Web of Science ®Google Scholar
• Almanzar VMD, Shah K, LaComb JF, et al. 5-FU-miR-15a inhibits activation of pancreatic stellate cells by reducing YAP1 and BCL-2 levels in vitro. Int J Mol Sci. 2023 Feb 16;24(4):3954. doi: 10.3390/ijms24043954
   PubMed Web of Science ®Google Scholar
• Li L, Wang G, Hu JS, et al. RB1CC1-enhanced autophagy facilitates PSCs activation and pancreatic fibrogenesis in chronic pancreatitis. Cell Death Dis. 2018 Sep 20;9(10):952. doi: 10.1038/s41419-018-0980-4
   PubMed Web of Science ®Google Scholar
• Yang WJ, Cao RC, Xiao W, et al. Acinar ATP8b1/LPC pathway promotes macrophage efferocytosis and clearance of inflammation during chronic pancreatitis development. Cell Death Dis. 2022 Oct 22;13(10):893. doi: 10.1038/s41419-022-05322-6
   PubMed Web of Science ®Google Scholar
• Abu Bakar NDB, Carlessi R, Gogoi-Tiwari J, et al. TWEAK/Fn14 signalling regulates the tissue microenvironment in chronic pancreatitis. Cancers (Basel). 2023 Mar 16;15(6):1807. doi: 10.3390/cancers15061807
   PubMed Web of Science ®Google Scholar
• Klauss S, Schorn S, Teller S, et al. Genetically induced vs. classical animal models of chronic pancreatitis: a critical comparison. Faseb J. 2018 Nov 1;32(11):5778–5792. doi: 10.1096/fj.201800241RR
   Web of Science ®Google Scholar
• Lew D, Afghani E, Pandol S. Chronic pancreatitis: current status and challenges for prevention and treatment. Dig Dis Sci. 2017 Jul 1;62(7):1702–1712. doi: 10.1007/s10620-017-4602-2
   PubMed Web of Science ®Google Scholar
• Bouwense SAW, Kempeneers MA, van Santvoort HC, et al. Surgery in chronic pancreatitis: indication, timing and procedures. Visc Med. 2019 Apr;35(2):110–118. doi: 10.1159/000499612
   PubMed Web of Science ®Google Scholar
• Cruz-Monserrate Z, Gumpper K, Pita V, et al. Biomarkers of chronic pancreatitis: a systematic literature review. Pancreatology. 2021 Mar;21(2):323–333. doi: 10.1016/j.pan.2021.01.006
   PubMed Web of Science ®Google Scholar